Search results
Microneedle Magic: New Alopecia Treatment Can Reverse Hair Loss
SciTechDaily· 5 days agoResearchers at MIT, Brigham and Women’s Hospital, and Harvard Medical School have developed a...
Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show...
Digital Journal· 4 days agoORLANDO, FL / ACCESSWIRE / May 10, 2024 / RedChip Companies will air interviews with Can-Fite BioPharma Ltd. (NYSE American:CANF) and Nutriband Inc. (NASDAQ:NTRB) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this
Brokers Offer Predictions for AnaptysBio, Inc.’s Q1 2025 Earnings (NASDAQ:ANAB)
ETF DAILY NEWS· 11 hours agoAnaptysBio, Inc. (NASDAQ:ANAB – Free Report) – Investment analysts at Wedbush issued their Q1 2025 earnings per share estimates for AnaptysBio in a research report issued on Thursday, May 9th ...
Japan's Takeda Pharma to restructure after annual profit slump
Reuters· 5 days ago, opens new tab announced a restructuring on Thursday after annual profit slid by more than half...
Takeda tackles $900m restructuring plan after generics hurt annual profits
Pharmaceutical Technology via Yahoo Finance· 5 days agoThese programs involve therapies to treat rare blood disorders, psoriasis and neurological...
Summer Hair Savior: Unveiling the Power of Olive Oil for Luscious Locks
Grazia USA· 1 day agoBeat summer hair woes with olive oil! Discover its benefits and DIY hair mask tips. Plus, our top...
AbbVie Inc. (NYSE:ABBV) Receives $174.31 Average Target Price from Brokerages
ETF DAILY NEWS· 3 days agoShares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the thirteen research firms that are presently covering the stock, MarketBeat ...
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
InvestorPlace via Yahoo Finance· 7 days agoAmid a challenging market environment, one of your best bets could be to target biotech stocks to...
3 Tried and True Dividend Stocks to Buy for Your Portfolio
InvestorPlace via Yahoo Finance· 7 days agoPicking income stocks can be challenging. Some companies pay dividends only to cut them in the...
Immunic advances ‘potentially groundbreaking’ MS therapy vidofludimus calcium during Q1
Proactive Investors· 6 days agoImmunic Inc (NASDAQ:IMUX) continued to advance its clinical programs for its lead drug asset,...